SCHEMBL31246323

SCHEMBL31246323

Cc1ccc(C(=O)P(=O)(C(=O)c2ccc(C)c(C)c2C)c2ccccc2)c(C)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA5A P35218 1/20 0.36
TSHR P16473 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
USP2 O75604 1/20 0.35
ESR1 P03372 1/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
ALDH1A1 P00352 3/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
AKR1B10 O60218 1/20 0.35
TRPA1 O75762 1/20 0.35
ABCB11 O95342 1/20 0.35
DHFR P00374 1/20 0.35
LMNA P02545 1/20 0.35
MPO P05164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1285564 1.00 CYP1A2 (0.36) CYP1A2CA2CA4CA5ATSHR
SCHEMBL29984769 0.86 KMT2A (0.38) CYP1A2CA2CA4CA5ATSHR
SCHEMBL28633825 0.86 LMNA (0.42) TSHRSMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL151071 0.86 KMT2A (0.38) CYP1A2CA2CA4CA5ATSHR
SCHEMBL1714766 0.85 CA2 (0.39) CYP1A2CA2CA4CA5ATSHR
SCHEMBL1714353 0.83 CYP1A2 (0.35) CYP1A2CA2CA4CA5ATSHR
SCHEMBL3886065 0.83 CA2 (0.38) CYP1A2CA2CA4CA5ATSHR
SCHEMBL3886068 0.82 CYP1A2 (0.34) CYP1A2CA2CA4CA5ATSHR
Lithium Ion SCHEMBL22346192 0.82 CYP1A2 (0.34) CYP1A2CA2CA4CA5ATSHR
SCHEMBL28647047 0.81 LMNA (0.36) CYP1A2TSHRSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120020192-A Ultraviolet light curing adhesive system for syringe needle cementing, preparation method and application thereof 中国石油化工股份有限公司 2025-05-20 CN claimed
CN-120020195-A Dual-curing adhesive system for syringe needle cementing, preparation method and application thereof 中国石油化工股份有限公司 2025-05-20 CN claimed
US-20260015646-A1 ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY MURATA MANUFACTURING CO (JP) 2026-01-15 US disclosed
CN-120020192-A Ultraviolet light curing adhesive system for syringe needle cementing, preparation method and application thereof 中国石油化工股份有限公司 2025-05-20 CN disclosed
CN-120020195-A Dual-curing adhesive system for syringe needle cementing, preparation method and application thereof 中国石油化工股份有限公司 2025-05-20 CN disclosed
WO-2024209808-A1 ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIOBATTERY 株式会社村田製作所 2024-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015646-A1 ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY SORD, NQO1, PDHB CYP1A2 386/4885CA2 673/4885CA4 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.